Core Viewpoint - The company has issued a correction regarding the notice for the second extraordinary general meeting of shareholders in 2025, specifically addressing the omission of a sub-proposal in the original announcement [1]. Summary by Relevant Sections Meeting Matters - The corrected notice includes details on voting proposals, confirming that there are three non-cumulative voting proposals and six cumulative voting proposals [1][4]. - The proposal regarding the revision of the "Compensation and Performance Assessment System for Directors, Supervisors, and Senior Management" is highlighted as a non-cumulative voting proposal [3][4]. Correction Details - The correction does not involve any substantive changes to the original notice, and the company emphasizes its commitment to improving the quality of information disclosure to prevent similar errors in the future [1][4].

证券代码：002360 证券简称：同德化工 公告编号：2025-085 山西同德化工股份有限公司 关于召开2025年第二次临时股东大会的通知（更正后） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山西同德化工股份有限公司（以下简称"公司"）第八届董事会第十四次会 议决定于2025年9月11日（星期四）召开公司2025年第二次临时股东大会。 一、召开会议的基本情况 1、股东会届次:2025年第二次临时股东大会 2、股东会的召集人：公司董事会 3、会议召开的合法性、合规性：公司第八届董事会第十四次会议审议通过 《关于提请召开2025年第二次临时股东大会的议案》，本次股东大会的召开符合 有关法律、法规、行政法规、部门规章、规范性文件及公司章程的规定。 4、会议召开时间： (1)现场会议时间:2025年9月11日(星期四)下午14：00 6、会议的股权登记日：2025年9月8日(星期一) 7、会议出席对象： （1）于2025年9月8日股权登记日下午收市时在中国结算深圳分公司登记在 册的公司全体股东均有权出席股东会。不能出席会议的股东，可以以书面形式委 托代理人出席 ...

证券代码：002360 证券简称：同德化工 公告编号：2025-084 山西同德化工股份有限公司 关于召开2025年第二次临时股东大会通知的更正公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 山西同德化工股份有限公司（以下简称"公司"）于2025年8月26日在《上 海证券报》《证券时报》及巨潮资讯网 （www.cninfo.com.cn）披露了《关于提 请召开2025年第二次临时股东大会的通知》（公告编号：2025-075），经事后审 查发现通知中提案5子议案缺失，现进行更正。本次更正不涉及原通知的实质性 变更，敬请投资者关注。具体内容如下： 更正前： ...... 二、会议事项： | 议案 | 议案名称 | 该列打勾的栏 | | --- | --- | --- | | 编码 | | 目可以投票 | | 100 | 总议案：除累积投票提案外的所有提案 | √ | | | 非累积投票提案 | | | 1.00 | 《关于修订<公司章程>及相关议事规则的议案》 | √作为投票对 象 议 | | | | 的 子 | | | | 案 数：3 | | 1.01 | ...

2025年8月26日，同德化工(002360.SZ)发布2025年半年度报告。截至2025年8月25日，共有1个机构投资 者披露持有同德化工A股股份，合计持股量达267.37万股，占同德化工总股本的0.67%。其中，机构投 资者包括BARCLAYS BANK PLC，机构投资者合计持股比例达0.67%。相较于上一季度，机构持股比例 合计上涨了0.67个百分点。 ...

Core Viewpoint - Shanxi Tongde Chemical Co., Ltd. has been listed as an executed party by the Shanghai Pudong New District People's Court with an execution target of 10,135,365 yuan as of August 22, 2025 [1][2]. Company Overview - Shanxi Tongde Chemical Co., Ltd. is a leading enterprise in the national civil explosive industry and a specialized and innovative small and medium-sized enterprise in Shanxi Province. The company was restructured into a joint-stock company in 2006 and was listed on the Shenzhen Stock Exchange in March 2010 [3][6]. Financial Performance - In the first half of 2025, the company reported operating revenue of 256 million yuan, a decrease of 19.32% year-on-year. The net profit attributable to shareholders was 11.09 million yuan, down 75.76% year-on-year. The net profit after deducting non-recurring gains and losses was 5.01 million yuan, a decline of 87.45% year-on-year [8][10]. - The basic and diluted earnings per share were both 0.03 yuan, representing a decrease of 72.73% compared to the previous year [10]. - The total assets at the end of the reporting period were approximately 4.62 billion yuan, a decrease of 1.72% from the previous year [10]. Business Operations - The company primarily engages in the research, production, and sales of civil explosives, including various types of explosives such as gel emulsified explosives and ammonium oil explosives. It has a strong market presence in Shanxi Province, which is a key area for civil explosive demand [6][7]. - The company aims to promote high-quality development by accelerating intelligent manufacturing and transformation, with significant improvements in safety production and management levels [7].

消息面上，同德化工披露2025年半年度报告，上半年实现营业收入2.56亿元，同比下降19.32%；归母净 利润1109.19万元，同比下滑75.76%。此外，公司董事长张烘因个人原因辞职，公司将于9月11日召开临 时股东大会。 截至2025年8月25日收盘，同德化工股价报5.44元，较前一交易日下跌0.37%，成交额0.57亿元。 资金流向方面，8月25日主力资金净流出143.65万元，近五日主力资金净流入101.23万元。 同德化工主营业务为民用炸药的研发、生产、销售及爆破工程服务。公司所属板块包括化学制品、山西 板块等。 风险提示：投资有风险，决策需谨慎。 ...

Core Viewpoint - Shanxi Tongde Chemical Co., Ltd. has corrected previous accounting errors and made retrospective adjustments to its financial statements for the first half and third quarter of 2024, as approved by the board and supervisory committee [1][2]. Financial Statements Summary 1. 2024 Half-Year Financial Statements - Total operating revenue for the first half of 2024 was CNY 316,837,887.42, a decrease from CNY 482,775,907.50 in the same period of 2023, representing a decline of approximately 34.4% [1]. - Total operating costs were CNY 261,875,892.68, down from CNY 372,249,730.57, indicating a reduction of about 29.6% [1]. - Net profit for the first half of 2024 was reported at CNY -1,619,682.64, compared to a profit of CNY 1,582,255.44 in the previous year [2]. - Basic and diluted earnings per share for the first half of 2024 were both CNY 0.11, down from CNY 0.22 in 2023 [3]. 2. 2024 Third Quarter Financial Statements - Total operating revenue for the third quarter of 2024 was CNY 416,584,306.71, a decrease from CNY 731,940,826.66 in the same quarter of 2023, reflecting a decline of approximately 43.1% [3]. - Total operating costs for the third quarter were CNY 362,410,865.54, down from CNY 562,980,703.44, indicating a reduction of about 35.6% [3]. - Net profit for the third quarter of 2024 was reported at CNY -2,259,571.89, compared to a profit of CNY 2,054,415.35 in the previous year [4]. - Basic and diluted earnings per share for the third quarter of 2024 were both CNY 0.10, down from CNY 0.37 in 2023 [4].

Core Viewpoint - The company has announced corrections to its financial statements for the first half and third quarter of 2024 due to accounting errors, which will not affect the annual financial statements for 2024 [1][2]. Financial Impact - The adjustments to the consolidated income statement for the first half of 2024 include: - Operating revenue adjusted from 470,368,952.07 to 316,837,887.42, a decrease of 153,531,064.65 [2] - Operating cost adjusted from 350,671,733.00 to 197,140,668.35, a decrease of 153,531,064.65 [2] - The adjustments to the consolidated income statement for the third quarter of 2024 include: - Operating revenue adjusted from 500,214,692.71 to 416,584,306.71, a decrease of 83,630,386.00 [2] - Operating cost adjusted from 346,388,412.68 to 262,758,026.68, a decrease of 83,630,386.00 [2] Governance and Compliance - The audit committee has reviewed the corrections and confirmed that they comply with relevant accounting standards and disclosure rules, ensuring that the financial data reflects the company's financial status accurately [3]. - The board of directors has also approved the corrections, emphasizing the importance of accurate financial reporting for improving the quality of financial information [3]. - The supervisory board has concurred with the audit committee and board's decisions, affirming that the correction process adheres to legal and regulatory requirements [4]. Future Measures - The company has committed to enhancing its financial oversight and monitoring to prevent similar accounting errors in the future, expressing regret for any inconvenience caused to investors [4].

Group 1 - The board meeting of Shanxi Tongde Chemical Co., Ltd. was held on August 23, 2025, with all 8 directors present, ensuring compliance with relevant laws and regulations [1] - The board approved several proposals, including amendments to the company's articles of association and rules for shareholder and board meetings, which will be submitted for review at the second extraordinary general meeting of shareholders in 2025 [2][3] - The meeting also discussed the establishment and revision of governance-related systems to enhance corporate governance and operational standards [3] Group 2 - The board approved the remuneration and performance evaluation system for directors, supervisors, and senior management, with unanimous support from all directors [4] - The board also approved the management system for the ownership and trading of the company's stock by directors, supervisors, and senior management, again with unanimous support [4] - Additional governance proposals, including the accountability system for significant errors in annual report disclosures and the registration and reporting system for insider information, were also approved [5][6] Group 3 - The company plans to hold the second extraordinary general meeting of shareholders on September 11, 2025, to discuss various proposals, including the appointment of a non-independent director and adjustments for prior accounting errors [7][9] - The full content of the revised governance systems will be disclosed on August 26, 2025, through designated information disclosure media [6][7]

Group 1 - The board meeting of Shanxi Tongde Chemical Co., Ltd. was held on August 25, 2025, with all 7 directors present, ensuring compliance with relevant laws and regulations [1][2] - The meeting passed a resolution regarding the resignation of the chairman and the delegation of responsibilities to a director to act as the chairman and legal representative [2]